Jay Duker - Chief Operating Officer, Eyepoint Pharmaceuticals, Inc
As of February 11, 2022
Jay Duker Net Worth
- Net worth is estimated to be at least $375K
- Owns at least 17,500 units of Eyepoint Pharmaceuticals, Inc stock
Jay Duker Trading
- Largest purchase of shares was 5,000 units , worth over $9.45K on April 3, 2019
- In total has made about 9 transactions over 4 years
- Usually trades in June, with the busiest year in 2019
Jay Duker
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Jay Duker Mailing Address
- Mailing address is C/o Eleven Biotherapeutics 215 1st St. #400 Cambridge MA 02142 MA
Eyepoint Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Nancy Lurker | 2020 | $581,957 | - | $482,460 | $563,216 | $454,508 | $15,660 | $2,097,801 |
| Nancy Lurker | 2019 | $577,037 | - | $650,207 | $693,165 | $144,034 | $15,340 | $2,079,783 |
| George Elston | 2020 | $440,000 | - | - | $83,104 | $236,940 | $15,660 | $775,704 |
| George Elston | 2019 | $58,385 | $20,000 | - | $635,555 | - | $2,068 | $716,008 |
| Dario Paggiarino | 2020 | $436,156 | - | $158,864 | $185,417 | $242,371 | $15,660 | $1,038,468 |
| Dario Paggiarino | 2019 | $420,862 | - | - | $275,775 | $105,188 | $15,340 | $817,165 |
| Scott Jones | 2020 | $376,250 | - | $158,864 | $185,417 | $212,135 | $15,660 | $948,326 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1314102/000156459021022639/eypt-def14a_20210622.htm
Eyepoint Pharmaceuticals, Inc Insider Trading
- The most recent transaction was 1,000 units bought on March 15, 2022 by Craig Michael Pine worth over $12.21K
- In the last 4 years, insiders at Eyepoint Pharmaceuticals, Inc sold an estimated value of $448.9K and bought an estimated value of $22.04M
- The most active traders are Nancy Lurker, President & CEO, Dario Paggiarino, Chief Medical Officer, and David Mazzo
- Insider trading is most common in June, with the busiest year in 2019
EyePoint Pharmaceuticals, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||